All studies
Not yet recruitingPHASE3INTERVENTIONAL

A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity

High blood pressure and living with excess weight are closely linked. Both can raise your risk of heart problems and stroke. This clinical trial is testing an experimental medicine called CagriSema to see if it helps lower blood pressure safely in people living with obesity. CagriSema combines two medicines into one injection: semaglutide (already approved for diabetes and weight loss) and cagrilintide (a new medicine). Participants will be randomly assigned to receive CagriSema, semaglutide on its own, cagrilintide on its own, or a dummy injection called a placebo. To be eligible, you must be 18 or older with a body mass index (BMI) of 30 or higher, and your top blood pressure number must be between 140 and 160 mmHg. People with well-managed type 2 diabetes may also take part. Joining involves regular clinic visits for health checks and tests.

At a glance

Status
Not yet recruiting
Phase
PHASE3
Sponsor
Novo Nordisk A/S
Enrolment target
1,408
Start
11 Nov 2026
Estimated completion
13 Jul 2028

What is this study about?

High blood pressure (hypertension) means your heart has to work harder than usual to pump blood around your body. Carrying extra weight often increases this pressure, putting added strain on your blood vessels and vital organs. Finding treatments that can safely lower blood pressure while helping people manage their weight could make a major difference to long-term health.

This study looks at a new treatment called CagriSema. It combines two drugs in a single injection: semaglutide, which is already used to treat type 2 diabetes and help with weight loss, and cagrilintide, an investigational drug that mimics a hormone that makes you feel full. Researchers want to see if combining these two medicines works better to lower blood pressure than using either drug on its own.

Because this is a phase 3 clinical trial, researchers are testing CagriSema in a large group of people to confirm how well it works and check for any side effects. Participants will be placed by chance into one of four groups: CagriSema, semaglutide, cagrilintide, or a harmless dummy treatment called a placebo. Comparing these groups helps researchers prove whether any health improvements are genuinely caused by the new medicine.

If the trial is successful, it could provide doctors with a new treatment option to help people manage both their blood pressure and their weight, potentially lowering their risk of serious conditions like heart attacks and strokes.

Key takeaways

  • Tests whether CagriSema safely lowers high blood pressure in people living with obesity.
  • Compares the new medicine against semaglutide, cagrilintide, and a dummy treatment (placebo).
  • Open to adults aged 18 and over with a BMI of 30 or higher and high blood pressure.
  • People with stable type 2 diabetes may also be eligible to join.
  • Taking part is completely voluntary and you can leave at any time.

Who may be eligible?

You may be able to join this study if you are 18 or older, have a body mass index (BMI) of 30 or more, and have a resting top (systolic) blood pressure reading between 140 and 160 mmHg. You can take part whether you are taking blood pressure tablets or not, as long as your treatment has been stable for at least 30 days.

People with type 2 diabetes can also take part, provided they were diagnosed at least three months ago, their blood sugar levels are within a set range, and their diabetes treatment has remained unchanged for at least 90 days.

You will not be able to join if your high blood pressure is caused by another specific health condition (such as certain kidney or hormone disorders), or if you are currently being tested for one. You will also be excluded if you experience sudden drops in blood pressure when you stand up that make you feel dizzy.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or over.
  2. My body mass index (BMI) is 30 or higher.
  3. My top blood pressure reading is usually between 140 and 160 mmHg.
  4. My current blood pressure medicines (if any) have not changed in the last 30 days.
  5. I do not get severe dizziness or blood pressure drops when standing up.
Answer every question to see your result.

What does participation involve?

If you take part, you will be asked to attend regular appointments at a specialist study clinic. A computer will randomly assign you to one of the treatment groups, and neither you nor your study doctor will know which treatment you are receiving. The study medicine is given as an injection under the skin. During visits, the research team will check your blood pressure, measure your weight, take blood and urine samples, and ask about your general health. You will be closely monitored throughout the trial, and the team will explain the full schedule of visits and total study length before you agree to join.

Potential risks and benefits

Taking part may help improve your blood pressure or weight, and you will receive comprehensive health checks from a specialist medical team throughout the study. However, there is no guarantee you will directly benefit, and you might receive a placebo. Like all medicines, the study drugs can cause side effects, most commonly stomach-related issues such as nausea, diarrhoea, or constipation. Your participation is entirely voluntary, and you are free to leave the trial at any time without it affecting your standard NHS care.

Locations (212)

  • John Muir Physicians Network
    Verified postcode
    Concord, United States
  • Aurora FDRC Inc.
    Verified postcode
    Costa Mesa, United States
  • Providence Medical Foundation
    Verified postcode
    Fullerton, United States
  • Catalina Research Institute, LLC
    Verified postcode
    Montclair, United States
  • Desert Oasis Hlthcr Med Group
    Verified postcode
    Palm Springs, United States
  • N America Res Inst - San Dimas
    Verified postcode
    San Dimas, United States
  • Chase Medical Research LLC
    Verified postcode
    Waterbury, United States
  • Clinical Res Of W Florida Inc
    Verified postcode
    Clearwater, United States
  • Renstar Medical Research
    Verified postcode
    Ocala, United States
  • Florida Institute for Clinical research
    Verified postcode
    Orlando, United States
  • Javara Inc. / Privia Medical Group Georgia LLC
    Verified postcode
    Albany, United States
  • Hope Clin Res & Wellness
    Verified postcode
    Conyers, United States

Common questions

What is CagriSema?

CagriSema is a new investigational medicine that combines semaglutide and cagrilintide into one injection to help manage weight and blood pressure.

What is a placebo?

A placebo is a dummy injection that looks identical to the real medicine but contains no active ingredients. It helps scientists see if the real drug truly makes a difference.

Do I have to pay to take part in this trial?

No. All study medicines, tests, and clinic visits are provided free of charge, and travel costs are usually refunded.

Can I carry on seeing my regular GP?

Yes. You will continue with your usual NHS care, and the study team will keep your GP updated about your progress.

What happens if I change my mind after starting?

You can leave the study at any point. You do not have to give a reason, and your regular medical care will not be affected.

How to find out more

Novo Nordisk

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "A Research Study to Investigate How Well the Medicine CagriS…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.